Hutchmed begins phase-three trials of lymphoma therapy in China
23rd Mar 2026 10:21
(Alliance News) - Hutchmed China Ltd on Monday said it had begun phase-three clinical trials of its lymphoma treatment in China. Read More
| Price | 220.00p on 17-04-2026 at 18:35:13 |
|---|---|
| Change | 0.00p 0% |
| Buy | 230.00p |
| Sell | 221.00p |
| Last Trade: | Sell 6,121.00 at 220.00p |
| Day's Volume: | 160,922 |
| Last Close: | 220.00p |
| Open: | 230.00p |
| ISIN: | KYG4672N1198 |
| Day's Range | 216.00p - 230.00p |
| 52wk Range: | 192.00p - 292.00p |
| Market Capitalisation: | £1.89b |
| VWAP: | 225.10651p |
| Shares in Issue: | 859.74m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 6,121 | 220.00p | Uncrossing Trade |
16:35:26 - 17-Apr-26 |
| Sell* | 1,373 | 221.00p | Automatic Execution |
16:15:54 - 17-Apr-26 |
| Sell* | 216 | 224.00p | Automatic Execution |
16:15:54 - 17-Apr-26 |
| Buy* | 216 | 225.00p | Automatic Execution |
16:14:51 - 17-Apr-26 |
| Sell* | 204 | 216.00p | Automatic Execution |
16:14:51 - 17-Apr-26 |
| Sell* | 1,500 | 216.00p | Automatic Execution |
16:14:51 - 17-Apr-26 |
| Sell* | 2,000 | 220.00p | Automatic Execution |
16:14:51 - 17-Apr-26 |
| Sell* | 1,751 | 221.00p | Ordinary |
15:34:40 - 17-Apr-26 |
| Sell* | 1 | 221.50p | Ordinary |
15:13:38 - 17-Apr-26 |
| Sell* | 4,000 | 223.07p | Ordinary |
15:11:55 - 17-Apr-26 |
Hutchmed (HCM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 9:30 am | RNS | 2025 Annual Report and Notice of AGM |
| 9th Apr 2026 7:00 am | RNS-R | Data to be Presented at AACR Annual Meeting 2026 |
| 23rd Mar 2026 7:00 am | RNS-R | HUTCHMED Initiates Phase III Trial of HMPL-760 |
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 16th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 11th Mar 2026 8:30 am | RNS | Vesting of awards under Long Term Incentive Plan |
| 9th Mar 2026 9:30 am | RNS | Update on Licensed Oncology Product in China |
| 6th Mar 2026 8:30 am | RNS | Directorate change |
| 5th Mar 2026 1:00 pm | RNS-R | Publication of Form 20-F |